Randomised Evaluation of Sodium Dialysate Levels on Vascular Events

Recruiting now · Phase 4

Conditions studied: End-Stage Kidney Disease

In brief

This global study will assess the effect of randomising dialysis sites to one of two default dialysate sodium concentrations in current practice, 140mmol/l and 137mmol/l, on major cardiovascular events and death in patients receiving maintenance haemodialysis.

Key facts

Study ID
NCT02823821
Run by
University of Sydney
People needed
50000
Starts
2016-06-01
Expected to finish
2026-12-01
Last updated by the study team
2025-04-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.